HEADER SIGNALING PROTEIN 02-MAR-21 7NR3 TITLE DISCOVERY OF ASTX029, A CLINICAL CANDIDATE WHICH MODULATES THE TITLE 2 PHOSPHORYLATION AND CATALYTIC ACTIVITY OF ERK1/2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MAPK 1,ERT1,EXTRACELLULAR SIGNAL-REGULATED KINASE 2,ERK-2, COMPND 5 MAP KINASE ISOFORM P42,P42-MAPK,MITOGEN-ACTIVATED PROTEIN KINASE 2, COMPND 6 MAPK 2; COMPND 7 EC: 2.7.11.24; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAPK1, ERK2, PRKM1, PRKM2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE7) KEYWDS SERINE-THREONINE KINASE, PROTEIN KINASE, SIGNAL TRANSDUCTION, MAP KEYWDS 2 KINASE, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR M.O'REILLY REVDAT 1 06-OCT-21 7NR3 0 JRNL AUTH T.D.HEIGHTMAN,V.BERDINI,L.BEVAN,I.M.BUCK,M.G.CARR,A.COURTIN, JRNL AUTH 2 J.E.COYLE,J.E.H.DAY,C.EAST,L.FAZAL,C.M.GRIFFITHS-JONES, JRNL AUTH 3 S.HOWARD,J.KUCIA-TRAN,V.MARTINS,S.MUENCH,J.M.MUNCK,D.NORTON, JRNL AUTH 4 M.O'REILLY,N.PALMER,P.PATHURI,T.M.PEAKMAN,M.READER,D.C.REES, JRNL AUTH 5 S.J.RICH,A.SHAH,N.G.WALLIS,H.WALTON,N.E.WILSHER, JRNL AUTH 6 A.J.WOOLFORD,M.COOKE,D.COUSIN,S.ONIONS,J.SHANNON,J.WATTS, JRNL AUTH 7 C.W.MURRAY JRNL TITL DISCOVERY OF ASTX029, A CLINICAL CANDIDATE WHICH MODULATES JRNL TITL 2 THE PHOSPHORYLATION AND CATALYTIC ACTIVITY OF ERK1/2. JRNL REF J.MED.CHEM. V. 64 12286 2021 JRNL REFN ISSN 0022-2623 JRNL PMID 34387469 JRNL DOI 10.1021/ACS.JMEDCHEM.1C00905 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 (19-MAR-2020) REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.06 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.7 REMARK 3 NUMBER OF REFLECTIONS : 29100 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.186 REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : 0.236 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.160 REMARK 3 FREE R VALUE TEST SET COUNT : 1503 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 51 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.92 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 57.41 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 582 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.3421 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 557 REMARK 3 BIN R VALUE (WORKING SET) : 0.3408 REMARK 3 BIN FREE R VALUE : 0.3721 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.30 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 25 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2757 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 48 REMARK 3 SOLVENT ATOMS : 361 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.66 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.02860 REMARK 3 B22 (A**2) : -3.88690 REMARK 3 B33 (A**2) : 2.85840 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 3.14760 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.240 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.167 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.155 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.280 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.151 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.943 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.912 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 5725 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 10372 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1276 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 909 ; 16.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 5719 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 369 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4875 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.013 REMARK 3 BOND ANGLES (DEGREES) : 1.07 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 6.23 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.58 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|11 - A|365 } REMARK 3 ORIGIN FOR THE GROUP (A): -1.1831 3.6888 37.8530 REMARK 3 T TENSOR REMARK 3 T11: -0.0058 T22: -0.0380 REMARK 3 T33: 0.0431 T12: 0.0266 REMARK 3 T13: 0.0002 T23: -0.0221 REMARK 3 L TENSOR REMARK 3 L11: 0.5147 L22: 0.4728 REMARK 3 L33: 0.5593 L12: -0.5873 REMARK 3 L13: 0.4128 L23: -0.2777 REMARK 3 S TENSOR REMARK 3 S11: -0.1425 S12: -0.0381 S13: 0.0744 REMARK 3 S21: 0.0988 S22: 0.1184 S23: -0.0814 REMARK 3 S31: -0.0472 S32: -0.0924 S33: 0.0241 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7NR3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 02-MAR-21. REMARK 100 THE DEPOSITION ID IS D_1292114482. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-MAY-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E+ REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 300K REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29169 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.897 REMARK 200 RESOLUTION RANGE LOW (A) : 46.060 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.2 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 65.2 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: BUSTER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.74 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.31 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.25M (NH4)2SO4 33% MPEG 2000 0.02M REMARK 280 MERCAPTOETHANOL 0.1M PH=7.2 HEPES/NAOH, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 35.35000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 290 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16100 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -18.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -7 REMARK 465 ALA A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 HIS A -3 REMARK 465 HIS A -2 REMARK 465 HIS A -1 REMARK 465 HIS A 0 REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 ALA A 3 REMARK 465 ALA A 4 REMARK 465 ALA A 5 REMARK 465 ALA A 6 REMARK 465 ALA A 7 REMARK 465 GLY A 8 REMARK 465 ALA A 9 REMARK 465 GLY A 10 REMARK 465 LYS A 330 REMARK 465 PHE A 331 REMARK 465 ASP A 332 REMARK 465 MET A 333 REMARK 465 GLU A 334 REMARK 465 LEU A 335 REMARK 465 ASP A 336 REMARK 465 ASP A 337 REMARK 465 LEU A 338 REMARK 465 GLY A 357 REMARK 465 TYR A 358 REMARK 465 ARG A 359 REMARK 465 SER A 360 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 14 -60.83 -134.12 REMARK 500 ARG A 15 80.41 -152.26 REMARK 500 ASP A 20 43.98 -78.17 REMARK 500 ILE A 31 -66.74 -128.22 REMARK 500 TYR A 36 34.51 -142.06 REMARK 500 ASP A 149 45.28 -151.35 REMARK 500 ASP A 167 85.28 64.56 REMARK 500 ASN A 201 16.41 -163.13 REMARK 500 LEU A 294 49.69 -97.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7NQQ RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH A DIFFERENT LIGAND REMARK 900 RELATED ID: 7NQW RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH A DIFFERENT LIGAND DBREF 7NR3 A 1 360 UNP P28482 MK01_HUMAN 1 360 SEQADV 7NR3 MET A -7 UNP P28482 INITIATING METHIONINE SEQADV 7NR3 ALA A -6 UNP P28482 EXPRESSION TAG SEQADV 7NR3 HIS A -5 UNP P28482 EXPRESSION TAG SEQADV 7NR3 HIS A -4 UNP P28482 EXPRESSION TAG SEQADV 7NR3 HIS A -3 UNP P28482 EXPRESSION TAG SEQADV 7NR3 HIS A -2 UNP P28482 EXPRESSION TAG SEQADV 7NR3 HIS A -1 UNP P28482 EXPRESSION TAG SEQADV 7NR3 HIS A 0 UNP P28482 EXPRESSION TAG SEQRES 1 A 368 MET ALA HIS HIS HIS HIS HIS HIS MET ALA ALA ALA ALA SEQRES 2 A 368 ALA ALA GLY ALA GLY PRO GLU MET VAL ARG GLY GLN VAL SEQRES 3 A 368 PHE ASP VAL GLY PRO ARG TYR THR ASN LEU SER TYR ILE SEQRES 4 A 368 GLY GLU GLY ALA TYR GLY MET VAL CYS SER ALA TYR ASP SEQRES 5 A 368 ASN VAL ASN LYS VAL ARG VAL ALA ILE LYS LYS ILE SER SEQRES 6 A 368 PRO PHE GLU HIS GLN THR TYR CYS GLN ARG THR LEU ARG SEQRES 7 A 368 GLU ILE LYS ILE LEU LEU ARG PHE ARG HIS GLU ASN ILE SEQRES 8 A 368 ILE GLY ILE ASN ASP ILE ILE ARG ALA PRO THR ILE GLU SEQRES 9 A 368 GLN MET LYS ASP VAL TYR ILE VAL GLN ASP LEU MET GLU SEQRES 10 A 368 THR ASP LEU TYR LYS LEU LEU LYS THR GLN HIS LEU SER SEQRES 11 A 368 ASN ASP HIS ILE CYS TYR PHE LEU TYR GLN ILE LEU ARG SEQRES 12 A 368 GLY LEU LYS TYR ILE HIS SER ALA ASN VAL LEU HIS ARG SEQRES 13 A 368 ASP LEU LYS PRO SER ASN LEU LEU LEU ASN THR THR CME SEQRES 14 A 368 ASP LEU LYS ILE CYS ASP PHE GLY LEU ALA ARG VAL ALA SEQRES 15 A 368 ASP PRO ASP HIS ASP HIS THR GLY PHE LEU THR GLU TYR SEQRES 16 A 368 VAL ALA THR ARG TRP TYR ARG ALA PRO GLU ILE MET LEU SEQRES 17 A 368 ASN SER LYS GLY TYR THR LYS SER ILE ASP ILE TRP SER SEQRES 18 A 368 VAL GLY CYS ILE LEU ALA GLU MET LEU SER ASN ARG PRO SEQRES 19 A 368 ILE PHE PRO GLY LYS HIS TYR LEU ASP GLN LEU ASN HIS SEQRES 20 A 368 ILE LEU GLY ILE LEU GLY SER PRO SER GLN GLU ASP LEU SEQRES 21 A 368 ASN CYS ILE ILE ASN LEU LYS ALA ARG ASN TYR LEU LEU SEQRES 22 A 368 SER LEU PRO HIS LYS ASN LYS VAL PRO TRP ASN ARG LEU SEQRES 23 A 368 PHE PRO ASN ALA ASP SER LYS ALA LEU ASP LEU LEU ASP SEQRES 24 A 368 LYS MET LEU THR PHE ASN PRO HIS LYS ARG ILE GLU VAL SEQRES 25 A 368 GLU GLN ALA LEU ALA HIS PRO TYR LEU GLU GLN TYR TYR SEQRES 26 A 368 ASP PRO SER ASP GLU PRO ILE ALA GLU ALA PRO PHE LYS SEQRES 27 A 368 PHE ASP MET GLU LEU ASP ASP LEU PRO LYS GLU LYS LEU SEQRES 28 A 368 LYS GLU LEU ILE PHE GLU GLU THR ALA ARG PHE GLN PRO SEQRES 29 A 368 GLY TYR ARG SER MODRES 7NR3 CME A 161 CYS MODIFIED RESIDUE HET CME A 161 10 HET SO4 A 401 5 HET SO4 A 402 5 HET UO5 A 403 68 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM SO4 SULFATE ION HETNAM UO5 6-[5-CHLORANYL-2-(OXAN-4-YLAMINO)PYRIMIDIN-4-YL]-2-[2- HETNAM 2 UO5 OXIDANYLIDENE-2-(1,2,4,5-TETRAHYDRO-3-BENZAZEPIN-3- HETNAM 3 UO5 YL)ETHYL]-3~{H}-ISOINDOL-1-ONE FORMUL 1 CME C5 H11 N O3 S2 FORMUL 2 SO4 2(O4 S 2-) FORMUL 4 UO5 C29 H30 CL N5 O3 FORMUL 5 HOH *361(H2 O) HELIX 1 AA1 HIS A 61 PHE A 78 1 18 HELIX 2 AA2 LEU A 112 GLN A 119 1 8 HELIX 3 AA3 SER A 122 ALA A 143 1 22 HELIX 4 AA4 LYS A 151 SER A 153 5 3 HELIX 5 AA5 ASP A 175 ASP A 179 5 5 HELIX 6 AA6 THR A 190 ARG A 194 5 5 HELIX 7 AA7 ALA A 195 MET A 199 5 5 HELIX 8 AA8 LYS A 207 ASN A 224 1 18 HELIX 9 AA9 HIS A 232 GLY A 245 1 14 HELIX 10 AB1 SER A 248 CYS A 254 1 7 HELIX 11 AB2 ASN A 257 SER A 266 1 10 HELIX 12 AB3 PRO A 274 PHE A 279 1 6 HELIX 13 AB4 ASP A 283 LEU A 294 1 12 HELIX 14 AB5 GLU A 303 ALA A 309 1 7 HELIX 15 AB6 HIS A 310 GLU A 314 5 5 HELIX 16 AB7 ASP A 318 GLU A 322 5 5 HELIX 17 AB8 LYS A 340 THR A 351 1 12 HELIX 18 AB9 ALA A 352 GLN A 355 5 4 SHEET 1 AA1 2 GLU A 12 MET A 13 0 SHEET 2 AA1 2 VAL A 18 PHE A 19 -1 O PHE A 19 N GLU A 12 SHEET 1 AA2 5 TYR A 25 GLY A 34 0 SHEET 2 AA2 5 GLY A 37 ASP A 44 -1 O TYR A 43 N THR A 26 SHEET 3 AA2 5 VAL A 49 ILE A 56 -1 O VAL A 49 N ASP A 44 SHEET 4 AA2 5 VAL A 101 ASP A 106 -1 O VAL A 101 N ILE A 56 SHEET 5 AA2 5 ASP A 88 ILE A 90 -1 N ASP A 88 O VAL A 104 SHEET 1 AA3 3 THR A 110 ASP A 111 0 SHEET 2 AA3 3 LEU A 155 LEU A 157 -1 O LEU A 157 N THR A 110 SHEET 3 AA3 3 LEU A 163 ILE A 165 -1 O LYS A 164 N LEU A 156 SHEET 1 AA4 2 VAL A 145 LEU A 146 0 SHEET 2 AA4 2 ARG A 172 VAL A 173 -1 O ARG A 172 N LEU A 146 LINK C THR A 160 N CME A 161 1555 1555 1.32 LINK C CME A 161 N ASP A 162 1555 1555 1.33 CISPEP 1 GLY A 22 PRO A 23 0 -2.50 CRYST1 48.835 70.700 60.354 90.00 109.40 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020477 0.000000 0.007211 0.00000 SCALE2 0.000000 0.014144 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017566 0.00000